FdaApplication
ANDA 210038
Identifiers
- fda_app_no: ANDA210038
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED PHARMA ESPANA SL |
| application_type | ANDA |
| approval_date | 2020-09-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAFTIFINE HYDROCHLORIDE | NAFTIFINE HYDROCHLORIDE | 2% | CREAM;TOPICAL |
1 product